17-Dimethylaminoethylamino-17-demethoxygeldanamycin,

Code: d5193-1mg D2-231

Not available outside of the UK & Ireland.

Application

17-DMAG has been used to block the NF-κB inflammatory cascade in the murine model. It a potential therapeutic agent for non-small-cell lung cancers (NSCLC).


read more

Your Price
£348.00 1MG

Not available outside of the UK & Ireland.

Application

17-DMAG has been used to block the NF-κB inflammatory cascade in the murine model. It a potential therapeutic agent for non-small-cell lung cancers (NSCLC).

Biochem/physiol Actions

17-DMAG is a heat shock protein (HSP90) inhibitor. 17-DMAG is a more potent analog of geldanamycin. It inhibits cancer growth and promotes apoptosis in multiple cell lines. 17-DMAG is a more potent antitumor agent than 17-AAG.

General description

Chemical structure: benzenoid

antibiotic activity spectrumneoplastics
biological sourcesynthetic
colordark red-purple to black
formpowder
mode of actionprotein synthesis | interferes
Quality Level100
solubilityethanol: ~10 mg/mL (lit.), DMSO: >25 mg/mL (lit.)
storage temp.−20°C
Cas Number467214-20-6
This product has met the following criteria: